KIDS icon

OrthoPediatrics

20.82 USD
-0.73
3.39%
At close Apr 30, 4:00 PM EDT
After hours
20.82
+0.00
0.00%
1 day
-3.39%
5 days
-0.48%
1 month
-15.47%
3 months
-13.75%
6 months
-22.89%
Year to date
-8.96%
1 year
-29.73%
5 years
-57.38%
10 years
11.04%
 

About: OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercialize implants and instruments to meet the needs of surgeons and patients. Its products, include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia and ACL Reconstruction System among others.

Employees: 562

0
Funds holding %
of 7,425 funds
0
Analysts bullish %
of 5 analysts

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

657% more call options, than puts

Call options by funds: $53K | Put options by funds: $7K

0.66% more ownership

Funds ownership: 67.47% [Q3] → 68.13% (+0.66%) [Q4]

10% less repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 39

13% less funds holding

Funds holding: 124 [Q3] → 108 (-16) [Q4]

14% less capital invested

Capital invested by funds: $443M [Q3] → $383M (-$60.3M) [Q4]

53% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 30

Research analyst outlook

5 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$24
15%
upside
Avg. target
$37
78%
upside
High target
$50
140%
upside

5 analyst ratings

positive
80%
neutral
20%
negative
0%
Truist Securities
Richard Newitter
55% 1-year accuracy
28 / 51 met price target
15%upside
$24
Hold
Maintained
11 Apr 2025
Needham
Mike Matson
36% 1-year accuracy
43 / 121 met price target
102%upside
$42
Buy
Reiterated
9 Apr 2025
Lake Street
Ben Haynor
33% 1-year accuracy
3 / 9 met price target
78%upside
$37
Buy
Initiated
7 Apr 2025
Citizens Capital Markets
David Turkaly
37% 1-year accuracy
10 / 27 met price target
140%upside
$50
Market Outperform
Reiterated
21 Mar 2025
Stifel
Rick Wise
30% 1-year accuracy
10 / 33 met price target
54%upside
$32
Buy
Maintained
5 Mar 2025

Financial journalist opinion

Neutral
GlobeNewsWire
1 week ago
OrthoPediatrics Corp. to Report First Quarter Financial Results on May 7, 2025
WARSAW, Ind., April 23, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its first quarter 2025 financial results on May 7, 2025 after the market closes.
OrthoPediatrics Corp. to Report First Quarter Financial Results on May 7, 2025
Neutral
GlobeNewsWire
3 weeks ago
OrthoPediatrics Corp. Expands Scoliosis Portfolio with Launch of VerteGlide™ System
WARSAW, Ind., April 08, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the U.S. launch of the new VerteGlide Spinal Growth Guidance System, used to treat Early Onset Scoliosis (“EOS”). This represents the company's 80th system designed to treat musculoskeletal issues in children.
OrthoPediatrics Corp. Expands Scoliosis Portfolio with Launch of VerteGlide™ System
Neutral
GlobeNewsWire
1 month ago
OrthoPediatrics Corp. to Participate in the 24th Annual Needham Virtual Healthcare Conference
WARSAW, Ind., March 25, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that Dave Bailey, President & Chief Executive Officer, and Fred Hite, Chief Operating Officer, and Chief Financial Officer, are scheduled to participate in a fireside chat at the 24th Annual Needham Virtual Healthcare Conference.
OrthoPediatrics Corp. to Participate in the 24th Annual Needham Virtual Healthcare Conference
Neutral
GlobeNewsWire
1 month ago
OrthoPediatrics Corp. Named One the 2025 Best Places to Work in Indiana
WARSAW, Ind., March 24, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced it was selected as one of the 2025 Best Places to Work in Indiana. This is the 9th time the Company has been recognized by the annual program created by the Indiana Chamber of Commerce.
OrthoPediatrics Corp. Named One the 2025 Best Places to Work in Indiana
Neutral
GlobeNewsWire
1 month ago
OrthoPediatrics Corp. Joins Crossroads Pediatric Device Consortium to Advance Pediatric Medical Device Innovation
WARSAW, Ind., March 17, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today its partnership with the Crossroads Pediatric Device Consortium (CPDC). This collaboration aligns with the Company's cause of improving the lives of children by supporting the development and commercialization of innovative pediatric medical devices.​
OrthoPediatrics Corp. Joins Crossroads Pediatric Device Consortium to Advance Pediatric Medical Device Innovation
Neutral
Seeking Alpha
1 month ago
OrthoPediatrics Corp. (KIDS) Q4 2024 Earnings Call Transcript
OrthoPediatrics Corp. (NASDAQ:KIDS ) Q4 2024 Earnings Conference Call March 4, 2025 4:30 PM ET Company Participants Trip Taylor - Gilmartin Group, IR David Bailey - President and CEO Fred Hite - Chief Operating and Financial Officer Conference Call Participants Ryan Zimmerman - BTIG Rick Wise - Stifel Matthew O'Brien - Piper Sandler Joseph Conway - Needham & Company Operator Hello. And welcome to OrthoPediatrics Corporation's Fourth Quarter and Full Year 2024 Earnings Conference Call.
OrthoPediatrics Corp. (KIDS) Q4 2024 Earnings Call Transcript
Neutral
Zacks Investment Research
1 month ago
Compared to Estimates, OrthoPediatrics (KIDS) Q4 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for OrthoPediatrics (KIDS) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Compared to Estimates, OrthoPediatrics (KIDS) Q4 Earnings: A Look at Key Metrics
Negative
Zacks Investment Research
1 month ago
OrthoPediatrics (KIDS) Reports Q4 Loss, Misses Revenue Estimates
OrthoPediatrics (KIDS) came out with a quarterly loss of $0.29 per share versus the Zacks Consensus Estimate of a loss of $0.22. This compares to loss of $0.23 per share a year ago.
OrthoPediatrics (KIDS) Reports Q4 Loss, Misses Revenue Estimates
Neutral
GlobeNewsWire
1 month ago
OrthoPediatrics Corp. Reports Fourth Quarter and Full Year 2024 Financial Results
Record full year 2024 revenue of $204.7 million increased 38% compared to prior year, and more than doubled fourth quarter 2024 adjusted EBITDA WARSAW, Ind., March 04, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today its financial results for the fourth quarter and full year ended December 31, 2024.
OrthoPediatrics Corp. Reports Fourth Quarter and Full Year 2024 Financial Results
Neutral
GlobeNewsWire
2 months ago
OrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025
WARSAW, Ind., Feb. 19, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its fourth quarter and full year 2024 financial results on Tuesday, March 4, 2025 after the market closes. OrthoPediatrics will host a conference call on Tuesday, March 4, 2025 at 4:30 p.m. ET to discuss the results.
OrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025
Charts implemented using Lightweight Charts™